<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue journalpublishing.dtd?><?DTDIdentifier.IdentifierType system?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Vis</journal-id><journal-id journal-id-type="publisher-id">MV</journal-id><journal-title-group><journal-title>Molecular Vision</journal-title></journal-title-group><issn pub-type="epub">1090-0535</issn><publisher><publisher-name>Molecular Vision</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">20</article-id><article-id pub-id-type="publisher-id">2009MOLVIS0440</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Differential expression of transforming growth factor-&#x003b2; isoforms in bullous keratopathy corneas</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Strzalka-Mrozik</surname><given-names>Barbara</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Stanik-Walentek</surname><given-names>Agnieszka</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kapral</surname><given-names>Malgorzata</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kowalczyk</surname><given-names>Malgorzata</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Adamska</surname><given-names>Jolanta</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gola</surname><given-names>Joanna</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mazurek</surname><given-names>Urszula</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><aff id="aff1"><label>1</label>Department of Molecular Biology, Medical University of Silesia, Sosnowiec, Poland</aff><aff id="aff2"><label>2</label>Department of Ophthalmology, Medical University of Silesia, Sosnowiec, Poland</aff><aff id="aff3"><label>3</label>Department of Biochemistry, Medical University of Silesia, Sosnowiec, Poland</aff><aff id="aff4"><label>4</label>Department of Medical Genetics, Medical University of Silesia, Sosnowiec, Poland</aff></contrib-group><author-notes><corresp id="cor1">Correspondence to: Dr Barbara Strzalka-Mrozik, Department of Molecular Biology, Medical University of Silesia, Narcyzow 1, 41-200 Sosnowiec, Poland; Phone: +48 32 364 10 26; FAX: +48 32 364 10 20; email: address: <email xlink:href="bstrzalka@sum.edu.pl">bstrzalka@sum.edu.pl</email></corresp></author-notes><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>05</day><month>2</month><year>2010</year></pub-date><volume>16</volume><fpage>161</fpage><lpage>166</lpage><history><date date-type="received"><day>21</day><month>12</month><year>2009</year></date><date date-type="accepted"><day>02</day><month>2</month><year>2010</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2010 Molecular Vision.</copyright-statement><copyright-year>2010</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Purpose</title><p>The aim of this study was to investigate transcriptional activities of genes encoding transforming growth factor (TGF)-&#x003b2; isoforms in bullous keratopathy corneas.</p></sec><sec><title>Methods</title><p>The study group consisted of 45 patients with bullous keratopathy (22 females and 23 males). The control group included 45 corneal donors (21 females and 24 males). Quantification of <italic>TGF-&#x003b2;1</italic>, <italic>TGF-&#x003b2;2</italic>, and <italic>TGF-&#x003b2;3</italic> mRNAs was performed by real-time quantitative reverse transcription PCR (QRT-PCR).</p></sec><sec><title>Results</title><p><italic>TGF-&#x003b2;1</italic>, <italic>TGF-&#x003b2;2</italic>, and <italic>TGF-&#x003b2;3</italic> mRNAs were detected in both normal and pseudophakic bullous keratopathy (PBK) corneas. We found significantly lower transcriptional activity of <italic>TGF-&#x003b2;3</italic> mRNA in bullous keratopathy corneas compared to normal tissues. <italic>TGF-&#x003b2;1</italic> and <italic>TGF-&#x003b2;2</italic> expressions were at the same level in both PBK and healthy corneas.</p></sec><sec><title>Conclusions</title><p>Downregulation of <italic>TGF-&#x003b2;3</italic> gene expression may play a significant role in molecular changes observed in bullous keratopathy.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>GalleyStatus</meta-name><meta-value>Last eX pass/corrections</meta-value></custom-meta><custom-meta><meta-name>corr-author</meta-name><meta-value>Strzalka-Mrozik</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Pseudophakic bullous keratopathy (PBK) is a complication of cataract surgery with intraocular lens placement and is an indication for corneal transplantation. Clinical hallmarks of this disease are chronic corneal edema due to corneal endothelial cell dysfunction, subepithelial bullae (blisters), and loss of transparency [<xref ref-type="bibr" rid="r1">1</xref>-<xref ref-type="bibr" rid="r3">3</xref>]. This disease is also characterized by extensive fibrosis with abnormal deposition of extracellular matrix proteins, tenascin-C, and fibrillin [<xref ref-type="bibr" rid="r1">1</xref>,<xref ref-type="bibr" rid="r4">4</xref>,<xref ref-type="bibr" rid="r5">5</xref>]. Moreover, PBK is often accompanied by scarring and neovascularization [<xref ref-type="bibr" rid="r3">3</xref>].</p><p>Various cytokines and growth factors are strongly involved in these processes [<xref ref-type="bibr" rid="r6">6</xref>,<xref ref-type="bibr" rid="r7">7</xref>]. One of the most important mediators is the family of transforming growth factors &#x003b2; (TGF-&#x003b2;), composed of five isoforms (TGF-&#x003b2;1-5) [<xref ref-type="bibr" rid="r8">8</xref>,<xref ref-type="bibr" rid="r9">9</xref>]. Among them, only TGF-&#x003b2;1, &#x003b2;2, and &#x003b2;3 are found in humans [<xref ref-type="bibr" rid="r9">9</xref>,<xref ref-type="bibr" rid="r10">10</xref>]. The TGF-&#x003b2; family of cytokines regulates such fundamental aspects of cellular function as cell growth, differentiation, inflammation, and wound healing [<xref ref-type="bibr" rid="r11">11</xref>-<xref ref-type="bibr" rid="r13">13</xref>]. In addition, there is substantial evidence suggesting participation of TGF-&#x003b2; in many human diseases [<xref ref-type="bibr" rid="r13">13</xref>-<xref ref-type="bibr" rid="r15">15</xref>], including fibrotic pathologies of the eye [<xref ref-type="bibr" rid="r16">16</xref>-<xref ref-type="bibr" rid="r18">18</xref>].</p><p>In vitro TGF-&#x003b2; isoforms have a similar effect on biologic tissues; however, in vivo they are generally characterized by varied degrees of expression and different functions. Their biologic activity depends on quantitative relationships between individual isoforms [<xref ref-type="bibr" rid="r19">19</xref>-<xref ref-type="bibr" rid="r21">21</xref>]. TGF-&#x003b2;1 and TGF-&#x003b2;2 isoforms have been reported to play a profibrotic role, whereas TGF-&#x003b2;3 possesses antifibrotic activity [<xref ref-type="bibr" rid="r22">22</xref>]. Embryonic wounds with a high level of TGF-&#x003b2;3 and low levels of TGF-&#x003b2;1 and TGF-&#x003b2;2 heal with no scarring [<xref ref-type="bibr" rid="r23">23</xref>]. During scar-forming in adults, however, TGF-&#x003b2;1 and TGF-&#x003b2;2 expression is significantly higher than TGF-&#x003b2;3 expression during wound healing. Such relationships during development of bullous keratopathy as a result of cornea injury after cataract surgery remain unclear.</p><p>Therefore, the present study focuses on transcriptional activities of genes encoding TGF-&#x003b2;1, TGF-&#x003b2;2, and TGF-&#x003b2;3 isoforms in human corneas with bullous keratopathy. Quantitative relationships between mRNA levels of these three isoforms were also assessed.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Tissues</title><p>Normal human corneas used as controls were taken within 12 h after death from 45 donors (21 females and 24 males; mean age 53.4 years; range 42&#x02013;65 years). Inclusion criteria for becoming a corneal tissue donor were determined by the Eye Bank Association of America (EBAA).</p><p>The patient group involved 45 individuals (22 females and 23 males; mean age 56.1 years; range 45&#x02013;65 years) with a clinical diagnosis of PBK, treated in the Department of Ophthalmology, Medical University of Silesia, St. Barbara Hospital, Katowice, Poland. The PBK diagnosis was based on the presence of chronic corneal stromal and epithelial edema, painful epithelial bullae with recurrent erosions as well as signs and symptoms of chronic ocular irritation. Exclusion criteria were as follows: the absence of inflammation and degeneration of anterior and posterior segment of eyeball, corneal neovascularization, diabetic retinopathy, pseudoexfoliation syndrome (PEX) and glaucoma. All patients were subjected to cataract surgery in the past; the difference in time between cataract surgery and corneal transplantation averaged 32.4 months. PBK corneas were obtained within 12 h of penetrating keratoplasty.</p><p>Surgical anesthesia was as follows: Fentanyl (2 mg), Midazolam (2 mg), Athropine (0,01 mg/kg body mass), Thiopental (4-5 mg/kg body mass), Vecuronium (0,1 mg/kg body mass). Because only the central corneal buttons (7.5&#x000a0;mm diameter) were available for PBK corneas, normal corneas were trephined, and only the central portions were used. Tissue specimens were stored in EUSOL C (Alchimia, Padova, Italy) at &#x02013;70&#x000a0;&#x000b0;C for 24 h until RNA extraction. The research was approved by the Bioethics Committee of Medical University of Silesia, Katowice, Poland (NN-6501&#x02013;146/06). All patients were informed about the research and signed an informed consent form.</p></sec><sec><title>RNA extraction from tissue specimens</title><p>Total RNA was extracted from the specimens using a commercially available kit (Total RNA Prep Plus Kit; A&#x00026;A Biotechnology, Gdansk, Poland) based on acid guanidinium-thiocyanate phenol-chloroform method by Chomczynski and Sacchi, according to the manufacturer's instructions. RNA extracts were treated with DNase I (MBI Fermentas, Vilnius, Lithuania). The quality of extracts was checked electrophoretically using an 0.8% agarose (Sigma-Aldrich, Munich, Germany) gel stained with ethidium bromide (Sigma-Aldrich). Results were analyzed and recorded using the gel documentation system 1D Bas-Sys (Biotech-Fisher, Perth, Australia). Total RNA concentration was determined by spectrophotometric measurement using the Gene Quant II RNA/DNA Calculator (Pharmacia Biotech, Cambridge, UK).</p></sec><sec><title>Real-time quantitative reverse transcription-PCR assay</title><p>Transcriptional activities of <italic>TGF-&#x003b2;1</italic>, <italic>TGF-&#x003b2;2</italic>, <italic>TGF-&#x003b2;3</italic>, and glyceraldehyde-3-phosphate dehydrogenase (<italic>GAPDH</italic>) genes were evaluated using real time quantitative reverse transcription (QRT)-PCR and SYBR Green I chemistry (QuantiTect&#x000ae; SYBR&#x000ae; Green RT-PCR kit; QIAGEN, Valencia, CA). Analysis was performed using an Opticon&#x02122; DNA Engine Continuous Fluorescence Detector (MJ Research, Watertown, MA). All samples were tested in triplicate. <italic>GAPDH</italic> was included to monitor the QRT-PCR efficiency. Oligonucleotide primers specific for <italic>TGF-&#x003b2;1</italic>, <italic>TGF-&#x003b2;2</italic>, <italic>TGF-&#x003b2;3</italic>, and <italic>GAPDH</italic> genes were described previously by Strzalka et al. [<xref ref-type="bibr" rid="r24">24</xref>,<xref ref-type="bibr" rid="r25">25</xref>] and Ercolani et al. [<xref ref-type="bibr" rid="r26">26</xref>], respectively (<xref ref-type="table" rid="t1">Table 1</xref>). The thermal profile for one-step RT-PCR was as follows: reverse transcription at 50&#x000a0;&#x000b0;C for 30 min, denaturation at 95&#x000a0;&#x000b0;C for 15 min, 50 cycles consisting of temperatures 94&#x000a0;&#x000b0;C for 15 s, 60&#x000a0;&#x000b0;C for 30 s, and 72&#x000a0;&#x000b0;C for 30 s. To detect the expression profile of each investigated gene, commercially available standards of &#x003b2;-actin (<italic>ACTB</italic>) cDNA (TaqMan<sup>&#x000ae;</sup> DNA Template Reagent kit; PE Applied Biosystems, Inc., Foster, CA) were used at five different concentrations (ranging from 400 to 8,000 copies of <italic>ACTB</italic> cDNA), as recommended by Bustin [<xref ref-type="bibr" rid="r27">27</xref>]. Amplification plots for each standard template were used to determine the cycle threshold values (Ct). A standard curve was generated by plotting the Ct values against the log of the known amount of the <italic>ACTB</italic> cDNA copy number. The obtained results of the mRNA copy number were recalculated per 1 &#x003bc;g of total RNA. Each run was completed using melting curve analysis to confirm specificity of the amplification and absence of the primer dimers. The RT-PCR products were also separated in 6% polyacrylamide gels (PAA) and visualized with silver salts.</p><table-wrap id="t1" position="float"><label>Table 1</label><caption><title>Characteristic of primers used for amplification.</title></caption><table frame="hsides" rules="groups"><col width="63" span="1"/><col width="286" span="1"/><col width="85" span="1"/><col width="36" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Gene</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Sequence of primers</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Length of amplicon (bp)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Tm (&#x000ba;C)</bold></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>GAPDH</italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Forward: 5&#x02019;-GAAGGTGAAGGTCGGAGTC-3&#x02019;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">226<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">80<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Reverse: 5&#x02019;-GAAGATGGTGATGGGATTC-3&#x02019;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>TGF&#x003b2;-1</italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Forward:5&#x02019;TGAACCGGCCTTTCCTGCTTCTCATG3&#x02019;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">151<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">85<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Reverse: 5&#x02019;GCGGAAGTCAATGTACAGCTGCCGC3&#x02019;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>TGF&#x003b2;-2</italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Forward: 5&#x02019;TACTACGCCAAGGAGGTTTACAAA3&#x02019;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">201<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">80<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Reverse: 5&#x02019;TTGTTCAGGCACTCTGGCTTT3&#x02019;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>TGF&#x003b2;-3</italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Forward: 5&#x02019;CTGGATTGTGGTTCCATGCA3&#x02019;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">121<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">81<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;</td><td valign="top" align="left" rowspan="1" colspan="1">Reverse: 5&#x02019;TCCCCGAATGCCTCACAT3&#x02019;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table><table-wrap-foot><p>In the table, bp indicates base pairs and Tm indicates melting temperature.</p></table-wrap-foot></table-wrap></sec><sec><title>Statistical analyses</title><p>Statistical analyses were performed using Statistica 8.0 software (StatSoft, Tulsa, OK), with a significance level set at p&#x0003c;0.05. Values are expressed as median (Me), minimum, and maximum. The Kruskal&#x02013;Wallis one-way analysis of variance test and post hoc multiple test based on the average ranks were applied to assess differences in the expression of <italic>TGF-&#x003b2;</italic> isoforms in normal and pathological tissues. Comparison of transcriptional activity of examined genes between normal and PBK corneas was made using the Mann&#x02013;Whitney <italic>U</italic> test.</p></sec></sec><sec sec-type="results"><title>Results</title><p>In the present study, transcriptional activity of <italic>TGF-&#x003b2;</italic> isoforms in both normal and bullous keratopathy human corneas was determined using real-time QRT-PCR. In the first step of the study, specificity of the RT-PCR assay for the target genes was confirmed experimentally on the basis of the amplimers&#x02019; melting temperatures. For each RT-PCR product, a single peak at the expected temperature was observed: <italic>TGF-&#x003b2;1</italic> 85.4&#x000a0;&#x000b0;C; <italic>TGF-&#x003b2;2</italic> 80.0&#x000a0;&#x000b0;C; <italic>TGF-&#x003b2;3</italic> 80.6&#x000a0;&#x000b0;C; <italic>GAPDH</italic> 80.1&#x000a0;&#x000b0;C (data not shown). Gel electrophoresis also revealed the presence of a single product of the predicted length (<xref ref-type="fig" rid="f1">Figure 1</xref>).</p><fig id="f1" fig-type="figure" position="float"><label>Figure 1</label><caption><p>Reverse transcription PCR products separated in 6% polyacrylamide gel. lane 1, marker of size pBR 322/BsuRI (MBI Fermentas, Vilnius, Lithuania); lane 2, transforming growth factor -&#x003b2;1 (152 base pair, bp); lane 3, transforming growth factor -&#x003b2;2 (201 bp); lane 4, transforming growth factor -&#x003b2;3 (121 bp); lane 5 glyceraldehyde-3-phosphate dehydrogenase (226 bp). </p></caption><graphic xlink:href="mv-v16-161-f1"/></fig><p>In the next step, levels of <italic>TGF-&#x003b2;1</italic>, <italic>TGF-&#x003b2;2</italic>, and <italic>TGF-&#x003b2;3</italic> mRNAs in normal and bullous keratopathy human corneas were assessed and the quantitative relations among the mRNA of these three isoforms were then evaluated (<xref ref-type="fig" rid="f2">Figure 2A,B</xref>). <italic>TGF-&#x003b2;1</italic>, <italic>TGF-&#x003b2;2</italic>, and <italic>TGF-&#x003b2;3</italic> isoforms were detected in all tested samples obtained from normal corneas (<italic>TGF-&#x003b2;1</italic> Me=4,693.0 copies/&#x003bc;g RNA; <italic>TGF-&#x003b2;2</italic> Me=719.0 copies/&#x003bc;g RNA; <italic>TGF-&#x003b2;3</italic> Me=3,844.7 copies/&#x003bc;g RNA) and bullous keratopathy corneas (<italic>TGF-&#x003b2;1</italic> Me=5,553.0 copies/&#x003bc;g RNA; <italic>TGF-&#x003b2;2</italic> Me=738.9 copies/&#x003bc;g RNA; <italic>TGF-&#x003b2;3</italic> Me=2,176.5 copies/&#x003bc;g RNA). Comparable analysis of all <italic>TGF-&#x003b2;</italic> mRNA copies/&#x003bc;g of total RNA revealed the following relationships in healthy cornea: <italic>TGF-&#x003b2;1</italic>&#x0003e;<italic>TGF-&#x003b2;2</italic> (p=0.0164, post hoc test); <italic>TGF-&#x003b2;3</italic>&#x0003e;<italic>TGF-&#x003b2;2</italic> (p&#x0003c;0.001, post hoc test); <italic>TGF-&#x003b2;1</italic>=<italic>TGF-&#x003b2;3</italic> (not significant [NS], post hoc test). Pathologically changed cornea relationships were similar to that observed in normal cornea: <italic>TGF-&#x003b2;1</italic>&#x0003e;<italic>TGF-&#x003b2;2</italic> (p&#x0003c;0.001, post hoc test); <italic>TGF-&#x003b2;3</italic>&#x0003e;<italic>TGF-&#x003b2;2</italic> (p=0.0221, post hoc test); <italic>TGF-&#x003b2;1</italic>=<italic>TGF-&#x003b2;3</italic> (NS, post hoc test). In PBK corneas <italic>TGF-&#x003b2;3</italic> mRNA expression was found to be significantly lower (Mann&#x02013;Whitney <italic>U</italic> test, p=0.0107) compared to normal tissues (<xref ref-type="fig" rid="f2">Figure 2C</xref>). However, transcriptional activity of the <italic>TGF-&#x003b2;1</italic> (p=0.0585) and <italic>TGF-&#x003b2;2</italic> (p=0.5540) genes in both healthy and PBK corneas was at the same level.</p><fig id="f2" fig-type="figure" position="float"><label>Figure 2</label><caption><p>Transforming growth factor &#x003b2; in normal human corneas and pseudophakic bullous keratopathy corneas. The expression of transforming growth factor -&#x003b2;1, transforming growth factor -&#x003b2;2, and transforming growth factor -&#x003b2;3 isoforms in (<bold>A</bold>) normal human corneas (Kruskal&#x02013;Wallis one-way analysis of variance test; p=0.0003) and (<bold>B</bold>) pseudophakic bullous keratopathy corneas (Kruskal&#x02013;Wallis one-way analysis of variance test; p&#x0003c;0.0001). <bold>C</bold>: Comparison of transforming growth factor -&#x003b2;3 gene expression between pseudophakic bullous keratopathy and normal corneas (Mann&#x02013;Whitney U test, p=0.0107).</p></caption><graphic xlink:href="mv-v16-161-f2"/></fig></sec><sec sec-type="discussion"><title>Discussion</title><p>The role of <italic>TGF-&#x003b2;1</italic>, <italic>TGF-&#x003b2;2</italic>, and <italic>TGF-&#x003b2;3</italic> in the cornea is relatively well understood [<xref ref-type="bibr" rid="r10">10</xref>,<xref ref-type="bibr" rid="r13">13</xref>,<xref ref-type="bibr" rid="r28">28</xref>]. However, quantitative relationships between mRNA expressions of different isoforms in the course of some corneal pathologies are still unclear. In previously published reports mRNA expression of <italic>TGF-&#x003b2;</italic> was evaluated mostly in healthy tissues [<xref ref-type="bibr" rid="r10">10</xref>,<xref ref-type="bibr" rid="r21">21</xref>,<xref ref-type="bibr" rid="r24">24</xref>,<xref ref-type="bibr" rid="r25">25</xref>], and only a few authors have analyzed the expression profile of TGF-&#x003b2;1, TGF-&#x003b2;2, and TGF-&#x003b2;3 in the course of bullous keratopathy [<xref ref-type="bibr" rid="r1">1</xref>,<xref ref-type="bibr" rid="r3">3</xref>,<xref ref-type="bibr" rid="r5">5</xref>].</p><p>In the present study real-time RT-PCR was used to examine the mRNA expression of genes encoding <italic>TGF-&#x003b2;</italic> isoforms in human normal and pathologically changed cornea. Transcriptional activity was measured on the basis of the mRNA copy number per 1&#x000a0;&#x003bc;g of total RNA, following the recommendations of Tricarico et al. [<xref ref-type="bibr" rid="r29">29</xref>]. Transcripts of all three <italic>TGF-&#x003b2;</italic> isoforms were detected in PBK corneas and in healthy ones, which is in agreement with other published results when the examined material constituted cell cultures [<xref ref-type="bibr" rid="r10">10</xref>,<xref ref-type="bibr" rid="r30">30</xref>] or rat corneal epithelium [<xref ref-type="bibr" rid="r13">13</xref>,<xref ref-type="bibr" rid="r28">28</xref>].</p><p>Li et al. [<xref ref-type="bibr" rid="r21">21</xref>] reported that <italic>TGF-&#x003b2;1</italic> transcriptional activity was the highest in all tested parts of the anatomy of the eye. However, they studied the expression of genes encoding isoforms of <italic>TGF-&#x003b2;</italic> only in the healthy human cornea. This remains partly consistent with current results showing <italic>TGF-&#x003b2;1</italic> and <italic>TGF-&#x003b2;3</italic> as the predominant isoforms both in human healthy cornea and in affected cornea. Similar results were also demonstrated by Carrington et al. [<xref ref-type="bibr" rid="r31">31</xref>] and Tseng et al. [<xref ref-type="bibr" rid="r32">32</xref>]. Carrington et al. found <italic>TGF-&#x003b2;1</italic> to be the predominant isoform in the bovine cornea during wound healing. Tseng et al. postulated that healthy human cornea is characterized by high transcriptional activity of <italic>TGF-&#x003b2;1</italic>. However, Tuli et al. [<xref ref-type="bibr" rid="r12">12</xref>], based on investigations using animal models, revealed that damage of the corneal surface leads to an increase in expression of genes encoding <italic>TGF-&#x003b2;2</italic> and <italic>TGF-&#x003b2;3</italic>.</p><p>Of importance here is that only a fraction of previous studies shows quantitative relationships between <italic>TGF-&#x003b2;</italic> isoforms in the course of bullous keratopathy. Saghizadeh et al. [<xref ref-type="bibr" rid="r33">33</xref>] evaluated expression of the <italic>TGF-&#x003b2;2</italic> isoform both at the mRNA and protein levels in PBK and normal cornea; however statistically significant differences were not found. Kenney et al. [<xref ref-type="bibr" rid="r2">2</xref>] performed similar studies but revealed a significant increase in transcriptional activity of genes encoding isoforms of <italic>TGF-&#x003b2;1</italic> and <italic>TGF-&#x003b2;2</italic> in the course of bullous keratopathy. Their report contradicts our findings, which demonstrated that the differences in mRNA expression of both <italic>TGF-&#x003b2;1</italic> and <italic>TGF-&#x003b2;2</italic> genes in patients with bullous keratopathy compared to the control group were not statistically significant.</p><p>Interestingly, transcriptional activity of TGF-&#x003b2;3 was reduced in PBK compared to the control group. Data are lacking regarding <italic>TGF-&#x003b2;3</italic> expression in bullous keratopathy. Downregulation of transcriptional activity of <italic>TGF-&#x003b2;3</italic> in the present study may have been caused by the loss of keratinocytes observed in the course of PBK [<xref ref-type="bibr" rid="r34">34</xref>]. On the other hand, molecular mechanisms leading to a decrease in the <italic>TGF-&#x003b2;3</italic> mRNA level cannot be ruled out. After cataract surgery epithelial cells undergo epithelial-mesenchymal transition (EMT) [<xref ref-type="bibr" rid="r35">35</xref>]. In this process not only the morphology but also the transcriptional program of the epithelial cells is altered. After epithelial-mesenchymal transition cells become capable of expressing components of the extracellular matrix and probably other molecules, which can lead to reduced <italic>TGF-&#x003b2;3</italic> gene expression. The <italic>TGF-&#x003b2;3</italic> isoform is a potential therapeutic agent of corneal repair, especially as it has no harmful effect on corneal re-epithelialization [<xref ref-type="bibr" rid="r31">31</xref>]. Thus, early application of TGF-&#x003b2;3 during or shortly after cataract surgery would prevent patients from such complications as PBK. The question remains about whether such treatment in patients with bullous kerathopathy could restore normal corneal morphology, taking into account the role of TGF-&#x003b2;3 in tissue remodeling after wounding [<xref ref-type="bibr" rid="r22">22</xref>].</p><p>Summarizing the results of the present study, all three isoforms were found to be differentially expressed in the course of bullous kerathopathy, but only <italic>TGF-&#x003b2;3</italic> was changed compared to normal cornea. Obtained data suggest that decreased expression of <italic>TGF-&#x003b2;3</italic> may play a significant role in molecular changes observed in bullous keratopathy.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported by grant number NN-2-114/07 from the Medical University of Silesia, Katowice, Poland.</p></ack><ref-list><title>References</title><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ljubimov</surname><given-names>AV</given-names></name><name><surname>Burgeson</surname><given-names>RE</given-names></name><name><surname>Butkowski</surname><given-names>RJ</given-names></name><name><surname>Couchman</surname><given-names>JR</given-names></name><name><surname>Wu</surname><given-names>RR</given-names></name><name><surname>Ninomiya</surname><given-names>Y</given-names></name><name><surname>Sado</surname><given-names>Y</given-names></name><name><surname>Maguen</surname><given-names>E</given-names></name><name><surname>Nesburn</surname><given-names>AB</given-names></name><name><surname>Kenney</surname><given-names>MC</given-names></name></person-group><article-title>Extracellular matrix alterations in human corneas with bullous keratopathy.</article-title><source>Invest Ophthalmol Vis Sci</source><year>1996</year><volume>37</volume><fpage>997</fpage><lpage>1007</lpage><pub-id pub-id-type="pmid">8631643</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kenney</surname><given-names>MC</given-names></name><name><surname>Atilano</surname><given-names>SR</given-names></name><name><surname>Zorapapel</surname><given-names>N</given-names></name><name><surname>Holguin</surname><given-names>B</given-names></name><name><surname>Gaster</surname><given-names>RN</given-names></name><name><surname>Ljubimov</surname><given-names>AV</given-names></name></person-group><article-title>Altered expression of aquaporins in bullous keratopathy and Fuchs&#x02019; dystrophy corneas.</article-title><source>J Histochem Cytochem</source><year>2004</year><volume>52</volume><fpage>1341</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">15385580</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenbaum</surname><given-names>JT</given-names></name><name><surname>Planck</surname><given-names>ST</given-names></name><name><surname>Huang</surname><given-names>XN</given-names></name><name><surname>Rich</surname><given-names>L</given-names></name><name><surname>Ansel</surname><given-names>JC</given-names></name></person-group><article-title>Detection of mRNA for the cytokines, interleukin-l alpha and interleukin-8, in corneas from patients with pseudophakic bullous keratopathy.</article-title><source>Invest Ophthalmol Vis Sci</source><year>1995</year><volume>36</volume><fpage>2151</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">7657553</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ljubimov</surname><given-names>AV</given-names></name><name><surname>Saghizadeh</surname><given-names>M</given-names></name><name><surname>Spirin</surname><given-names>KS</given-names></name><name><surname>Mecham</surname><given-names>RP</given-names></name><name><surname>Sakai</surname><given-names>LY</given-names></name><name><surname>Kenney</surname><given-names>MC</given-names></name></person-group><article-title>Increased expression of fibrillin-1 in human corneas with bullous keratopathy.</article-title><source>Cornea</source><year>1998</year><volume>17</volume><fpage>309</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">9603388</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spirin</surname><given-names>KS</given-names></name><name><surname>Ljubimov</surname><given-names>AV</given-names></name><name><surname>Castellon</surname><given-names>R</given-names></name><name><surname>Wiedoeft</surname><given-names>O</given-names></name><name><surname>Marano</surname><given-names>M</given-names></name><name><surname>Sheppard</surname><given-names>D</given-names></name><name><surname>Kenney</surname><given-names>MC</given-names></name><name><surname>Brown</surname><given-names>DJ</given-names></name></person-group><article-title>Analysis of gene expression in human bullous keratopathy corneas containing limiting amounts of RNA.</article-title><source>Invest Ophthalmol Vis Sci</source><year>1999</year><volume>40</volume><fpage>3108</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">10586931</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kenney</surname><given-names>MC</given-names></name><name><surname>Zorapapel</surname><given-names>N</given-names></name><name><surname>Atilano</surname><given-names>S</given-names></name><name><surname>Chwa</surname><given-names>M</given-names></name><name><surname>Ljubimov</surname><given-names>A</given-names></name><name><surname>Brown</surname><given-names>D</given-names></name></person-group><article-title>Insulin-like growth factor-I (IGF-I) and transforming growth factor-beta (TGF-beta) modulate tenascin-C and fibrillin-1 in bullous keratopathy stromal cells in vitro.</article-title><source>Exp Eye Res</source><year>2003</year><volume>77</volume><fpage>537</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">14550395</pub-id></mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>H</given-names></name><name><surname>Siddiqui</surname><given-names>SS</given-names></name><name><surname>Shen</surname><given-names>X</given-names></name><name><surname>Malik</surname><given-names>AB</given-names></name><name><surname>Pulido</surname><given-names>JS</given-names></name></person-group><article-title>kumar NM, Yue BY. RNA interference targeting transforming growth factor-beta type II receptor suppresses ocular inflammation and fibrosis.</article-title><source>Mol Vis</source><year>2004</year><volume>10</volume><fpage>703</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">15475878</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Massague</surname><given-names>J</given-names></name></person-group><article-title>Mechanism of TGF- beta signaling from cell membrane to the nucleus.</article-title><source>Cell</source><year>2003</year><volume>113</volume><fpage>685</fpage><lpage>700</lpage><pub-id pub-id-type="pmid">12809600</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyons</surname><given-names>RM</given-names></name><name><surname>Moses</surname><given-names>HL</given-names></name></person-group><article-title>Transforming growth factors and regulation of cell proliferation.</article-title><source>Eur J Biochem</source><year>1990</year><volume>187</volume><fpage>467</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">2406131</pub-id></mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashida-Hibino</surname><given-names>S</given-names></name><name><surname>Watanabe</surname><given-names>H</given-names></name><name><surname>Nishida</surname><given-names>K</given-names></name><name><surname>Tsujikawa</surname><given-names>M</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Hori</surname><given-names>Y</given-names></name><name><surname>Saishin</surname><given-names>Y</given-names></name><name><surname>Tano</surname><given-names>Y</given-names></name></person-group><article-title>The effect of TGF-beta1 on differential gene expression profiles in human corneal epithelium studied by cDNA expression array.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2001</year><volume>42</volume><fpage>1691</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11431430</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawakita</surname><given-names>T</given-names></name><name><surname>Espana</surname><given-names>EM</given-names></name><name><surname>He</surname><given-names>H</given-names></name><name><surname>Hornia</surname><given-names>A</given-names></name><name><surname>Yeh</surname><given-names>LK</given-names></name><name><surname>Ouyang</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>CY</given-names></name><name><surname>Tseng</surname><given-names>SC</given-names></name></person-group><article-title>Keratocan expression of murine keratocytes is maintained on amniotic membrane by down-regulating transforming growth factor-beta signaling.</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>27085</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">15908433</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuli</surname><given-names>SS</given-names></name><name><surname>Liu</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Blalock</surname><given-names>TD</given-names></name><name><surname>Goldsein</surname><given-names>M</given-names></name><name><surname>Schultz</surname><given-names>GS</given-names></name></person-group><article-title>Immunohistochemical localization of EGF, TGF-alpha, TGF-beta, and their receptors in rat corneas during healing of excimer laser ablation.</article-title><source>Curr Eye Res</source><year>2006</year><volume>31</volume><fpage>709</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">16966143</pub-id></mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Michelini-Norris</surname><given-names>B</given-names></name><name><surname>Stevens</surname><given-names>S</given-names></name><name><surname>Rowsey</surname><given-names>J</given-names></name><name><surname>Ren</surname><given-names>X</given-names></name><name><surname>Goldstein</surname><given-names>M</given-names></name><name><surname>Schultz</surname><given-names>G</given-names></name></person-group><article-title>Measurement of mRNA for TGFss and extracellular matrix proteins in corneas of rats after PRK.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2000</year><volume>41</volume><fpage>4108</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">11095603</pub-id></mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gressner</surname><given-names>AM</given-names></name><name><surname>Weiskirchen</surname><given-names>R</given-names></name><name><surname>Breitkopf</surname><given-names>K</given-names></name><name><surname>Dooley</surname><given-names>S</given-names></name></person-group><article-title>Roles of TGF-beta in hepatic fibrosis.</article-title><source>Front Biosci</source><year>2002</year><volume>7</volume><fpage>d793</fpage><lpage>807</lpage><pub-id pub-id-type="pmid">11897555</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burgess</surname><given-names>HA</given-names></name><name><surname>Daugherty</surname><given-names>LE</given-names></name><name><surname>Thatcher</surname><given-names>TH</given-names></name><name><surname>Lakatos</surname><given-names>HF</given-names></name><name><surname>Ray</surname><given-names>DM</given-names></name><name><surname>Redonnet</surname><given-names>M</given-names></name><name><surname>Phipps</surname><given-names>RP</given-names></name><name><surname>Sime</surname><given-names>PJ</given-names></name></person-group><article-title>PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis.</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2005</year><volume>288</volume><fpage>L1146</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">15734787</pub-id></mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baum</surname><given-names>CL</given-names></name><name><surname>Arpey</surname><given-names>CJ</given-names></name></person-group><article-title>Normal cutaneous wound healing: clinical correlation with cellular and molecular events.</article-title><source>Dermatol Surg</source><year>2005</year><volume>31</volume><fpage>674</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">15996419</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klenkler</surname><given-names>B</given-names></name><name><surname>Sheardown</surname><given-names>H</given-names></name></person-group><article-title>Growth factors in the anterior segment: role in tissue maintenance, wound healing and ocular pathology.</article-title><source>Exp Eye Res</source><year>2004</year><volume>79</volume><fpage>677</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">15500826</pub-id></mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grose</surname><given-names>R</given-names></name><name><surname>Werner</surname><given-names>S</given-names></name></person-group><article-title>Wound-healing studies in transgenic and knockout mice.</article-title><source>Mol Biotechnol</source><year>2004</year><volume>28</volume><fpage>147</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">15477654</pub-id></mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>H</given-names></name><name><surname>Siddigui</surname><given-names>SS</given-names></name><name><surname>Shen</surname><given-names>X</given-names></name><name><surname>Malik</surname><given-names>AB</given-names></name><name><surname>Pulido</surname><given-names>JS</given-names></name><name><surname>Kumar</surname><given-names>NM</given-names></name><name><surname>Yue</surname><given-names>BY</given-names></name></person-group><article-title>RNA interference targeting transforming growth factor-beta type II receptor suppresses ocular inflammation and fibrosis.</article-title><source>Mol Vis</source><year>2004</year><volume>10</volume><fpage>703</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">15475878</pub-id></mixed-citation></ref><ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>HR</given-names></name><name><surname>Hong</surname><given-names>SB</given-names></name><name><surname>Kim</surname><given-names>YI</given-names></name><name><surname>Lee</surname><given-names>JW</given-names></name><name><surname>Kim</surname><given-names>NI</given-names></name></person-group><article-title>Differential expression of TGF-beta isoforms during differentiation of HaCaT human keratinocyte cells: implication for the separate role in epidermal differentiation.</article-title><source>J Korean Med Sci</source><year>2004</year><volume>19</volume><fpage>853</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15608397</pub-id></mixed-citation></ref><ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>DQ</given-names></name><name><surname>Lee</surname><given-names>SB</given-names></name><name><surname>Tseng</surname><given-names>SC</given-names></name></person-group><article-title>Differential expression and regulation of TGF-beta1, TGF-beta2, TGF-beta3, TGF-betaRI, TGF-betaRII and TGF-betaRIII in cultured human corneal, limbal, and conjunctival fibroblasts.</article-title><source>Curr Eye Res</source><year>1999</year><volume>19</volume><fpage>154</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">10420185</pub-id></mixed-citation></ref><ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jobling</surname><given-names>AI</given-names></name><name><surname>Nguyen</surname><given-names>M</given-names></name><name><surname>Gentle</surname><given-names>A</given-names></name><name><surname>McBrien</surname><given-names>N</given-names></name></person-group><article-title>Isoform-specific changes in scleral transforming growth factor-beta expression and the regulation of collagen synthesis during myopia progression.</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>18121</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">14752095</pub-id></mixed-citation></ref><ref id="r23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>MW</given-names></name><name><surname>O'Kane</surname><given-names>S</given-names></name></person-group><article-title>Scar-free healing: from embryonic mechanisms to adult therapeutic intervention.</article-title><source>Philos Trans R Soc Lond B Biol Sci</source><year>2004</year><volume>359</volume><fpage>839</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">15293811</pub-id></mixed-citation></ref><ref id="r24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strzalka</surname><given-names>B</given-names></name><name><surname>Dorecka</surname><given-names>M</given-names></name><name><surname>Stanik-Walentek</surname><given-names>A</given-names></name><name><surname>Kowalczyk</surname><given-names>M</given-names></name><name><surname>Kapral</surname><given-names>M</given-names></name><name><surname>Romaniuk</surname><given-names>W</given-names></name><name><surname>Mazurek</surname><given-names>U</given-names></name><name><surname>&#x0015a;wi&#x00105;tkowska</surname><given-names>L</given-names></name></person-group><article-title>Quantitative analysis of transforming growth factor &#x003b2; isoforms mRNA in the human corneal epithelium.</article-title><source>Folia Biol (Praha)</source><year>2008</year><volume>54</volume><fpage>46</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">18498721</pub-id></mixed-citation></ref><ref id="r25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strza&#x00142;ka</surname><given-names>B</given-names></name><name><surname>Mazurek</surname><given-names>U</given-names></name><name><surname>Dorecka</surname><given-names>M</given-names></name><name><surname>Stanik-Walentek</surname><given-names>A</given-names></name><name><surname>Romaniuk</surname><given-names>W</given-names></name></person-group><article-title>Quantitative analysis of TGF&#x003b2; isoforms mRNA and its receptors in the normal corneal tissue.</article-title><source>Sci Rev Pharm</source><year>2008</year><volume>4</volume><fpage>4</fpage><lpage>7</lpage></mixed-citation></ref><ref id="r26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ercolani</surname><given-names>L</given-names></name><name><surname>Florence</surname><given-names>B</given-names></name><name><surname>Denaro</surname><given-names>M</given-names></name><name><surname>Alexander</surname><given-names>M</given-names></name></person-group><article-title>Isolation and complete sequence of functional glyceraldehyde-3-phosphate dehydrogenase gene.</article-title><source>J Biol Chem</source><year>1988</year><volume>263</volume><fpage>15335</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">3170585</pub-id></mixed-citation></ref><ref id="r27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bustin</surname><given-names>SA</given-names></name></person-group><article-title>Absolute quantification of mRNA using real-time reverse transcriotion polymerase chain reaction assays.</article-title><source>J Mol Endocrinol</source><year>2000</year><volume>25</volume><fpage>169</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">11013345</pub-id></mixed-citation></ref><ref id="r28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zieske</surname><given-names>JD</given-names></name><name><surname>Hutcheon</surname><given-names>AE</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Chung</surname><given-names>EH</given-names></name><name><surname>Joyce</surname><given-names>NC</given-names></name></person-group><article-title>TGF-beta receptor types I and II are differentially expressed during corneal epithelial wound repair.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2001</year><volume>42</volume><fpage>1465</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">11381048</pub-id></mixed-citation></ref><ref id="r29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tricarico</surname><given-names>C</given-names></name><name><surname>Pinzani</surname><given-names>P</given-names></name><name><surname>Bianchi</surname><given-names>S</given-names></name><name><surname>Paglierani</surname><given-names>M</given-names></name><name><surname>Distante</surname><given-names>V</given-names></name><name><surname>Pazzagli</surname><given-names>M</given-names></name><name><surname>Bustin</surname><given-names>SA</given-names></name><name><surname>Orlando</surname><given-names>C</given-names></name></person-group><article-title>Quantitative real-time reverse transcription polymerase chain reaction: normalization to rRNA or single housekeeping genes is inappropriate for human tissue biopsies.</article-title><source>Anal Biochem</source><year>2002</year><volume>309</volume><fpage>293</fpage><lpage>300</lpage><pub-id pub-id-type="pmid">12413463</pub-id></mixed-citation></ref><ref id="r30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakravarti</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>F</given-names></name><name><surname>Vij</surname><given-names>N</given-names></name><name><surname>Roberts</surname><given-names>L</given-names></name><name><surname>Joyce</surname><given-names>S</given-names></name></person-group><article-title>Microarray studies reveal macrophage-like function of stromal keratocytes in the cornea.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2004</year><volume>45</volume><fpage>3475</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">15452052</pub-id></mixed-citation></ref><ref id="r31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrington</surname><given-names>LM</given-names></name><name><surname>Albon</surname><given-names>J</given-names></name><name><surname>Anderson</surname><given-names>I</given-names></name><name><surname>Kamma</surname><given-names>C</given-names></name><name><surname>Boulton</surname><given-names>M</given-names></name></person-group><article-title>Differential regulation of key stages in early corneal wound healing by TGF-beta isoforms and their inhibitors.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2006</year><volume>47</volume><fpage>1886</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">16638995</pub-id></mixed-citation></ref><ref id="r32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tseng</surname><given-names>SC</given-names></name><name><surname>Li</surname><given-names>DQ</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name></person-group><article-title>Suppression of transforming growth factor-beta isoforms, TGF-&#x003b2; receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix.</article-title><source>J Cell Physiol</source><year>1999</year><volume>179</volume><fpage>325</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">10228951</pub-id></mixed-citation></ref><ref id="r33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saghizadeh</surname><given-names>M</given-names></name><name><surname>Chwa</surname><given-names>M</given-names></name><name><surname>Aoki</surname><given-names>A</given-names></name><name><surname>Lin</surname><given-names>B</given-names></name><name><surname>Pirouzmanesh</surname><given-names>A</given-names></name><name><surname>Brown</surname><given-names>DJ</given-names></name><name><surname>Ljubimov</surname><given-names>AV</given-names></name><name><surname>Kenney</surname><given-names>MC</given-names></name></person-group><article-title>Altered expression of growth factors and cytokines in keratoconus, bullous keratopathy and diabetic human corneas.</article-title><source>Exp Eye Res</source><year>2001</year><volume>73</volume><fpage>179</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">11446768</pub-id></mixed-citation></ref><ref id="r34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuen</surname><given-names>HK</given-names></name><name><surname>Rassier</surname><given-names>CE</given-names></name><name><surname>Jardeleza</surname><given-names>MS</given-names></name><name><surname>Green</surname><given-names>WR</given-names></name><name><surname>de la Cruz</surname><given-names>Z</given-names></name><name><surname>Stark</surname><given-names>WJ</given-names></name><name><surname>Gottsch</surname><given-names>JD</given-names></name></person-group><article-title>A morphologic study of Fuchs dystrophy and bullous keratopathy.</article-title><source>Cornea</source><year>2005</year><volume>24</volume><fpage>319</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">15778606</pub-id></mixed-citation></ref><ref id="r35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saika</surname><given-names>S</given-names></name></person-group><article-title>TGF &#x003b2; pathobiology in the eye.</article-title><source>Lab Invest</source><year>2006</year><volume>86</volume><fpage>106</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">16341020</pub-id></mixed-citation></ref></ref-list></back></article>